Denileukin diftitox

DB00004ApprovedInvestigationalProtein Based TherapiesCD25-directed Cytotoxin

Denileukin diftitox is an IL2-receptor-directed cytotoxin indicated for the treatment of relapsed or refractory Stage I to III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. Denileukin diftitox is an IL2-receptor-directed cytotoxin, is a recombinant DNA-derived fusion protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met1-Thr387)-His and the sequence for human interleukin-2 (IL-2; Ala1-Thr133).

Protein structure of Denileukin diftitox
Mechanism
Curator reviewed · 6 references
Primary indication
Denileukin diftitox was previously indicated for the treatment of adult patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL) whose malignant cells express the CD25 component of the IL-2 receptor.Curator reviewed · 7 structured indications
Formula / weight
C2560H4042N678O799S17 · 58000.0 Da (approximate)
First approval
United States, 2013
Also known as
DAB(SUB 389)IL2 · Denileukin · Interleukin-2/diptheria toxin fusion protein · N-L-METHIONYL-387-L-HISTIDINE-388-L-ALANINE-1-388-TOXIN (CORYNEBACTERIUM DIPHTHERIAE STRAIN C7) (388->2') PROTEIN WITH 2-133-INTERLEUKIN 2 (HUMAN CLONE PTIL2-21A) · N-MET-187-HIS-388-ALA-1-388-TOXIN (CORYNEBACTERIUM DIPHTHERIAE C7) WITH 1-133-INTERLEUKIN 2
Code names
DAB-389IL2 · E-7272 · E-7777 · LY-335348
Brand names
  • Lymphir

Resolves to

What you can answer from here — as of July 17, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
42Drug interactionsStructured to mechanism, not free text
Sign in
36Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 20 drug categories
Sign in
21+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Denileukin diftitox, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account